The present project is aimed at determining the prevalence of LDL-C \<130 mg/dl with hsCRP ≥2mg/l, and of HDL-C \< 40 mg/dl in Spain together with the estimation of cardiovascular risk, to analyze the contribution of measuring hsCRP for primary prevention purposes. In a subgroup of that population a number of inflammatory and oxidative status biomarkers would be also measured to better understand the meaning of elevated hsCRP.The study aim to analyze data already collected in studies (11 studies will participate) carried out in Spain, in 10 Spanish regions, after the year 2000.
Study Type
OBSERVATIONAL
Enrollment
30,181
Research Site
Andalucia, Andalusia, Spain
Research Site
Canarias, Canary Islands, Spain
Research Site
Castilla Y Leon, Castille and León, Spain
Research Site
Talavero, Castille-La Mancha, Spain
Research Site
Girona, Catalonia, Spain
Research Site
Hospitalet, Catalonia, Spain
Research Site
Badajoz, Extremadura, Spain
Research Site
Madrid, Madrid, Spain
Research Site
Mallorca, Mallorca, Spain
Research Site
Murcia, Murcia, Spain
...and 1 more locations
Lipid fractions: high-density lipoprotein, low-density lipoprotein, and total cholesterol, and triglycerides, and dislipidemia treatments
Time frame: retrospectively
High sensitivity C reactive protein & CHR risk by Framingham adapted functions
Time frame: retrospectively
Lipid profile among the Spanish regions, as in the primary outcome variable
Time frame: retrospectively
Biomarkers: Interleukines 6 and 10, oxidized LDL, VCAM, ICAM, TNF alpha, neopterin, fibrinogen, lp(a), MMP 9 Apo A, Apo B, adiponectin, leptin, resistin, and yet other
Time frame: prospectively
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.